Provided are a water-soluble triarylphosphine for a palladium catalyst, which has high selectivity in a telomerization reaction and can be recovered with efficiency, an ammonium salt thereof, and a method for efficiently producing the same. Specifically, provided are bis(6-methyl-3-sulphophenyl)phenylphosphine; a bis(6-methyl-3-sulphonatopheyl)phenylphosphine diammonium salt obtained by reacting the phosphine with a tertiary amine having a total of 3 to 27 carbon atoms in groups bonded to one nitrogen atom; and a method for producing the same.

Provided are a water-soluble triarylphosphine for a palladium catalyst, which has high selectivity in a telomerization reaction and can be recovered with efficiency, an ammonium salt thereof, and a method for efficiently producing the same. Specifically, provided are bis(6-methyl-3-sulphophenyl)phenylphosphine; a bis(6-methyl-3-sulphonatopheyl)phenylphosphine diammonium salt obtained by reacting the phosphine with a tertiary amine having a total of 3 to 27 carbon atoms in groups bonded to one nitrogen atom; and a method for producing the same.

The present invention provides a high-purity arylsulfonic acid amine salt vinyl monomer which is an extremely industrially useful arylsulfonic acid monomer with excellent storage stability and amphiphilic solubility in both water and organic solvents, a simple and practical method for producing the same, a polyarylsulfonic acid amine salt which is a polymer thereof, and a method for producing the same. In the arylsulfonic acid amine salt vinyl monomer, a tertiary amine having 2 or 3 different substituents that each have 1 to 7 carbon atoms and also containing at least one or more of tertiary carbon or quaternary carbon or cyclic skeleton in the structure is applied to an amine moiety thereof, and in addition, a polyarylsulfonic acid amine salt having high purity in terms of sulfonation rate and polymerization conversion rate and a polymer thereof are used.

The surfactants which can be produced from the trialkylamine intermediates include the quaternary ammonium compounds of formula: ##STR00001##

The surfactants which can be produced from the trialkylamine intermediates include the quaternary ammonium compounds of formula: ##STR00001##

A carbon dioxide absorbent of an embodiment includes a chain amine, a cyclic amine, and an acid. The chain amine is a compound expressed by Formula (1) of FIG. 1. R.sup.1 in Formula (1) is hydrogen or an alkyl chain having at least one hydroxyl group and 1 to 7 carbon atoms. R.sup.2 in Formula (1) is an alkyl chain having at least one hydroxyl group and 1 to 7 carbon atoms. R.sup.3 in Formula (1) is hydrogen, a straight alkyl chain having 1 to 7 carbon atoms, a branched alkyl chain having 1 to 7 carbon atoms, or a cyclic alkyl chain having 5 to 7 carbon atoms.

A carbon dioxide absorbent of an embodiment includes a chain amine, a cyclic amine, and an acid. The chain amine is a compound expressed by Formula (1) of FIG. 1. R.sup.1 in Formula (1) is hydrogen or an alkyl chain having at least one hydroxyl group and 1 to 7 carbon atoms. R.sup.2 in Formula (1) is an alkyl chain having at least one hydroxyl group and 1 to 7 carbon atoms. R.sup.3 in Formula (1) is hydrogen, a straight alkyl chain having 1 to 7 carbon atoms, a branched alkyl chain having 1 to 7 carbon atoms, or a cyclic alkyl chain having 5 to 7 carbon atoms.

The instant invention provides for novel catiome lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower lipid levels in the liver. The present invention employs low molecular weight cationic lipids with one short lipid chain to enhance the efficiency and tolerability of in vivo delivery of siRNA.

The instant invention provides for novel catiome lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower lipid levels in the liver. The present invention employs low molecular weight cationic lipids with one short lipid chain to enhance the efficiency and tolerability of in vivo delivery of siRNA.

A catalyst, which can be used even under mild conditions and also has durability so as to enable repeated use while maintaining high activity, and with which a reduction reaction for converting an amide compound into an amine compound can be carried out, is provided by means of an amide compound hydrogenation reaction catalyst characterized in that platinum and vanadium are supported on a carrier and a method for producing an amine compound using the same.